Budget impact of intravenous iron therapy with ferric carboxymaltose in patients with chronic heart failure and iron deficiency in Germany
Author:
Affiliation:
1. Xcenda GmbH; Hannover 30159 Germany
2. ESiOR Oy; Kuopio 70100 Finland
3. Vifor Pharma Deutschland GmbH; Munich 81379 Germany
4. Center for Stroke Research and Department of Cardiology Charite Universitätsmedizin Berlin; Berlin 13353 Germany
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/ehf2.12179/fullpdf
Reference29 articles.
1. The pathophysiology of heart failure;Kemp;Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology,2012
2. Heart failure: preventing disease and death worldwide;Ponikowski;ESC Heart Failure,2014
3. The patient perspective: quality of life in advanced heart failure with frequent hospitalisations;Nieminen;Int J Cardiol,2015
4. Patient- and provider-related determinants of generic and specific health-related quality of life of patients with chronic systolic heart failure in primary care: a cross-sectional study;Peters-Klimm;Health Qual Life Outcomes,2010
5. Assessing patient preferences in heart failure using conjoint methodology;Pisa;Patient Prefer Adherence,2015
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Budget impact analyses for treatment of heart failure. A systematic review;Heart Failure Reviews;2024-03-16
2. Iron deficiency and supplementation in heart failure;Nature Reviews Cardiology;2024-02-07
3. Cost-Effectiveness and Budget Impact Analyses of Patient Blood Management in a Cardiovascular Surgery Department at Ankara Bilkent City Hospital in Turkey;Advances in Therapy;2023-12-19
4. Improvement of exercise and functional capacity and quality of life in patients with heart failure by iron therapy;Frontiers in Cardiovascular Medicine;2023-05-22
5. Impact of ferric carboxymaltose for iron deficiency at discharge after heart failure hospitalization: a European multinational economic evaluation;European Journal of Heart Failure;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3